Market Closed -
Other stock markets
|
Pre-market 07:00:16 am | |||
131.7 USD | +2.39% | 131.5 | -0.17% |
May. 15 | Merck to present new oncology data | CF |
May. 14 | US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.83% | 334B | |
+35.01% | 709B | |
+30.96% | 595B | |
-2.60% | 367B | |
+5.69% | 289B | |
+14.42% | 239B | |
+9.41% | 211B | |
-4.29% | 203B | |
+10.77% | 171B | |
+0.10% | 163B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- JPMorgan Chase Adjusts Price Target on Merck to $145 From $140